Jason A. Leverone
Chief Financial Officer · OnKure Therapeutics, Inc.
- 2024
- Sep 23, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason A. Leverone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nicholas A. Saccomano - $994 in OKUR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason A. Leverone?
Jason A. Leverone is a corporate insider, tracked as Chief Financial Officer of OnKure Therapeutics, Inc. (OKUR). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason A. Leverone submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jason A. Leverone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($4K) across all tracked filings.
